CEO exercised or converted 11K TECH derivative securities | OQRO Insider tradesWhy it stands out
Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Apr 22, 2026
- Reporting period
- Not applicable
- Filed with the SEC
- Apr 24, 2026
CEOOption exercise
Context
- Classification
option exercise
Code M — exercise or conversion of a derivative security
- Planned / mechanical clue
None found in footnotes
Only flagged when a footnote says so; never inferred
Source receipt
- Record ID
- 0000914190-26-000081
Added to OQROOct 2, 2026, 12:27 PM UTC Data qualityVerified: identifiers matched exactly Reporting personKim Kelderman RelationshipDirector, Officer Officer titleChief Executive Officer SecurityStock Option (Right to Buy) TableDerivative (Table II) Transaction dateApr 22, 2026 Acquired / disposedDisposed (D) Footnotes from the filing
- Fully exercisable.
Around the same time
Derivative exercise or conversion — not an open-market buy.
A board member of Bio-Techne sold $320K of Bio-Techne shares. Nobody planned it ahead of time.
Derivative exercise or conversion — not an open-market buy.